Ellipse Technologies is a privately held medical device company in Irvine, California focused on implantable remote-control technology for spinal and orthopedic deformity, trauma, and fracture management. Its core products are the MAGEC System (MAGnetic Expansion Control) for non-invasive adjustment of spinal implants and the PRECICE remote-control intramedullary rods for limb lengthening. Both MAGEC and PRECICE are CE‑Marked; MAGEC was launched at IMAST and PRECICE was displayed at the LLRS meeting, and the company has initiated clinical use outside the U.S. with planned international rollouts. Ellipse holds issued and pending patents covering its remote-control platforms and is developing additional devices for other orthopedic applications. The company recently completed a $17.6 million Series C financing to enable commercialization of MAGEC and PRECICE and to fund expanded uses of its patented technologies into new markets.

Total raised

$18M

Funding rounds

1

Latest round

Series C

Latest activity

Aug 2011